129 related articles for article (PubMed ID: 6503978)
1. [Local immunotherapy for cancer].
Hattori T; Niimoto M; Toge T; Hamamoto S; Seto Y; Kameda A; Tomoda S
Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1157-61. PubMed ID: 6503978
[TBL] [Abstract][Full Text] [Related]
2. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of intraperitoneal administration of a streptococcal preparation, OK-432, in carcinomatous peritonitis. I. Experimental study in the rat].
Saji S; Miya K; Oshita H; Nonomura O; Yokoyama Y; Yamamoto S; Takekoshi T; Sakata K
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1961-8. PubMed ID: 7184383
[TBL] [Abstract][Full Text] [Related]
4. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
Mukai M; Ando K; Koike S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
[TBL] [Abstract][Full Text] [Related]
6. [A case of recurrence of gastric cancer with an abdominal wall tumor responding to intratumoral OK-432 administration].
Saeki T; Kuninobu H; Niimoto M; Hattori T; Ohoya M; Yoshida H; Sata H; Kajitani Y
Gan No Rinsho; 1987 Apr; 33(4):417-20. PubMed ID: 2952818
[TBL] [Abstract][Full Text] [Related]
7. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
[TBL] [Abstract][Full Text] [Related]
8. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
9. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
10. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
[TBL] [Abstract][Full Text] [Related]
12. [Study on adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer].
Kikkawa N; Kawahara T
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1881-5. PubMed ID: 3382240
[TBL] [Abstract][Full Text] [Related]
13. A streptococcal preparation (OK-432) enhances monoclonal antibody NCC-ST-421 cytotoxicity against human colon cancer.
Kawano Y; Watanabe M; Kubota T; Nishibori H; Kurihara N; Teramoto T; Kitajima M
Anticancer Res; 1997; 17(4A):2449-53. PubMed ID: 9252661
[TBL] [Abstract][Full Text] [Related]
14. The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients.
Toge T; Kuninobu H; Yamaguchi Y; Baba N; Kegoya Y; Hattori T
Jpn J Surg; 1988 Nov; 18(6):668-74. PubMed ID: 3266768
[TBL] [Abstract][Full Text] [Related]
15. [Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors].
Akimoto M; Nishihira T; Hirakawa H; Abe M; Ohuchi N; Mori S; Kumagai K
Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):64-74. PubMed ID: 2014029
[TBL] [Abstract][Full Text] [Related]
16. [Case of malignant melanoma of the external genitalia responding satisfactorily to a combination of local injection of OK-432 and chemotherapy].
Satoh S; Suzuki A; Okamura H; Nishimura T
Gan To Kagaku Ryoho; 1982 Jan; 9(1):140-5. PubMed ID: 6820877
[TBL] [Abstract][Full Text] [Related]
17. [A case of bronchial carcinoma showing regression upon intratumoral administration of OK-432].
Onodera A; Miura K; Sasaki M; Sugiyama N; Kurokawa H; Shioya T; Kanazawa T
Gan To Kagaku Ryoho; 1988 Feb; 15(2):341-4. PubMed ID: 3341793
[TBL] [Abstract][Full Text] [Related]
18. [Effect of immunotherapy using the non-specific immunopotentiator OK-432 in malignant ovarian tumors--selecting appropriate cases for immunotherapy].
Nishida Y; Sakakibara K; Kano T; Ohta M; Tomoda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1017-25. PubMed ID: 3746020
[TBL] [Abstract][Full Text] [Related]
19. [Combined effect of the topical administration of OK-432 with radiation on the C3H mouse fibrosarcoma (NFSa)--TCD50 and the mechanism of action].
Mukai M; Ando K; Koike S; Nagao K; Isono K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3432-5. PubMed ID: 3789754
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy of non-resectable or recurrent cancer with a streptococcal preparation, OK-432--changes in immunologic parameters and evaluation of the periods of survival following intradermal and intramuscular injections].
Hanaue H; Nomoto S; Seto A; Kimura T; Kutsuna T; Takeuchi T; Yoshizaki S
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):1975-85. PubMed ID: 7169568
[No Abstract] [Full Text] [Related]
[Next] [New Search]
